Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chiral Pharma Corporation is a Philippines-based pharmaceutical company that specializes in the marketing, distribution, and sale of specialized healthcare products. The company focuses on high-value therapeutic areas including critical care, anesthesia, infectious diseases, and pain management. Chiral Pharma gained significant recognition for its role in the COVID-19 pandemic response by being one of the first to supply antiviral treatments like Remdesivir to the Philippine market. It operates by partnering with international manufacturers to bring essential and innovative medicines to local hospitals and healthcare providers. The company is committed to improving patient access to life-saving medications through a robust supply chain and regulatory expertise in the Southeast Asian region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chiral Pharma.